The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
A Critical Role for Natural Killer T Cells in Immunosurveillance of Methylcholanthrene-induced Sarcomas
Open accessAbstract
Natural killer (NK) T cells initiate potent antitumor responses when stimulated by exogenous factors such as interleukin (IL)-12 or α-galactosylceramide (α-GalCer), however, it is not clear whether this reflects a physiological role for these cells in tumor immunity. Through adoptive transfer of NK T cells from wild-type to NK T cell–deficient (T cell receptor [TCR] Jα281−/−) mice, we demonstrate a critical role for NK T cells in immunosurveillance of methylcholanthrene (MCA)-induced fibrosarcomas, in the absence of exogenous stimulatory factors. Using the same approach with gene-targeted and/or antibody-depleted donor or recipient mice, we have shown that this effect depends on CD1d recognition and requires the additional involvement of both NK and CD8+ T cells. Interferon-γ production by both NK T cells and downstream, non-NK T cells, is essential for protection, and perforin production by effector cells, but not NK T cells, is also critical. The protective mechanisms in this more physiologically relevant system are distinct from those associated with α-GalCer–induced, NK T cell–mediated, tumor rejection. This study demonstrates that, in addition to their importance in tumor immunotherapy induced by IL-12 or α-GalCer, NK T cells can play a critical role in tumor immunosurveillance, at least against MCA-induced sarcomas, in the absence of exogenous stimulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896
Kägi, D., Ledermann, B., Bürki, K., Seiler, P., Odermatt, B., Olsen, K. J., Podack, E. R., Zinkernagel, R. M., & Hengartner, H. (1994) · Nature · doi:10.1038/369031a0 · Cited by 1,757
Multiple Defects of Immune Cell Function in Mice with Disrupted Interferon-γ Genes
Dalton, D. K., Pitts-Meek, S., Keshav, S., Figari, I. S., Bradley, A., & Stewart, T. A. (1993) · Science · doi:10.1126/science.8456300 · Cited by 1,727
MOUSE CD1-SPECIFIC NK1 T CELLS: Development, Specificity, and Function
Bendelac, A., Rivera, M. N., Park, S.-H., & Roark, J. H. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.535 · Cited by 1,326
Requirement for V α 14 NKT Cells in IL-12-Mediated Rejection of Tumors
Cui, J., Shin, T., Kawano, T., Sato, H., Kondo, E., Toura, I., Kaneko, Y., Koseki, H., Kanno, M., & Taniguchi, M. (1997) · Science · doi:10.1126/science.278.5343.1623 · Cited by 1,237
An Activating Immunoreceptor Complex Formed by NKG2D and DAP10
Wu, J., Song, Y., Bakker, A. B. H., Bauer, S., Spies, T., Lanier, L. L., & Phillips, J. H. (1999) · Science · doi:10.1126/science.285.5428.730 · Cited by 1,039
Tracking the Response of Natural Killer T Cells to a Glycolipid Antigen Using Cd1d Tetramers
Matsuda, J. L., Naidenko, O. V., Gapin, L., Nakayama, T., Taniguchi, M., Wang, C.-R., Koezuka, Y., & Kronenberg, M. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.5.741 · Cited by 887
NKT cells: facts, functions and fallacies
Godfrey, D. I., Hammond, K. J. L., Poulton, L. D., Smyth, M. J., & Baxter, A. G. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01735-7 · Cited by 858
Self-citationCarnaud, C., Lee, D., Donnars, O., Park, S.-H., Beavis, A., Koezuka, Y., & Bendelac, A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.9.4647 · Cited by 854
Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells
Smyth, M. J., Thia, K. Y. T., Street, S. E. A., Cretney, E., Trapani, J. A., Taniguchi, M., Kawano, T., Pelikan, S. B., Crowe, N. Y., & Godfrey, D. I. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.4.661 · Cited by 829
Self-citationNKT cell–mediated repression of tumor immunosurveillance by IL-13 and the IL-4R–STAT6 pathway
Terabe, M., Matsui, S., Noben-Trauth, N., Chen, H., Watson, C., Donaldson, D. D., Carbone, D. P., Paul, W. E., & Berzofsky, J. A. (2000) · Nature Immunology · doi:10.1038/82771 · Cited by 699
CD1d1 Mutant Mice Are Deficient in Natural T Cells That PromptlyProduce IL-4
Mendiratta, S. K., Martin, W. D., Hong, S., Boesteanu, A., Joyce, S., & Van Kaer, L. (1997) · Immunity · doi:10.1016/s1074-7613(00)80290-3 · Cited by 595
In Vivo Identification of Glycolipid Antigen–Specific T Cells Using Fluorescent Cd1d Tetramers
Benlagha, K., Weiss, A., Beavis, A., Teyton, L., & Bendelac, A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.11.1895 · Cited by 556
Immunoglobulin E Production in the Absence of Interleukin-4-Secreting CD1-Dependent Cells
Smiley, S. T., Kaplan, M. H., & Grusby, M. J. (1997) · Science · doi:10.1126/science.275.5302.977 · Cited by 489
Impaired NK1+ T Cell Development and Early IL-4 Production in CD1-Deficient Mice
Chen, Y.-H., Chiu, N. M., Mandal, M., Wang, N., & Wang, C.-R. (1997) · Immunity · doi:10.1016/s1074-7613(00)80289-7 · Cited by 486
Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Sato, H., Kondo, E., Harada, M., Koseki, H., Nakayama, T., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5690 · Cited by 476
Hammond, K. J. L., Poulton, L. D., Palmisano, L. J., Silveira, P. A., Godfrey, D. I., & Baxter, A. G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.7.1047 · Cited by 474
Self-citationRüegg, C., Yilmaz, A., Bieler, G., Bamat, J., Chaubert, P., & Lejeune, F. J. (1998) · Nature Medicine · doi:10.1038/nm0498-408 · Cited by 450
Smyth, M. J., Crowe, N. Y., Pellicci, D. G., Kyparissoudis, K., Kelly, J. M., Takeda, K., Yagita, H., & Godfrey, D. I. (2002) · Blood · doi:10.1182/blood.v99.4.1259 · Cited by 392
Self-citationNK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma
Smyth, M. J., Crowe, N. Y., & Godfrey, D. I. (2001) · International Immunology · doi:10.1093/intimm/13.4.459 · Cited by 379
Self-citationNK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma
Smyth, M. J. (2008) · International Immunology · doi:10.1093/intimm/dxn028 · Cited by 377
Self-citationSonoda, K.-H., Exley, M., Snapper, S., Balk, S. P., & Stein-Streilein, J. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.9.1215 · Cited by 354
Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells
Eberl, G., & MacDonald, H. R. (2000) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(200004)30:4<985::aid-immu985>3.0.co;2-e · Cited by 326
The Anti-Tumor Activity of IL-12: Mechanisms of Innate Immunity That Are Model and Dose Dependent
Smyth, M. J., Taniguchi, M., & Street, S. E. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2665 · Cited by 301
Self-citationNKT cells are phenotypically and functionally diverse
Hammond, K. J. L., Pelikan, S. B., Crowe, N. Y., Randle-Barrett, E., Nakayama, T., Taniguchi, M., Smyth, M. J., van Driel, I. R., Scollay, R., Baxter, A. G., et al. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199911)29:11<3768::aid-immu3768>3.0.co;2-g · Cited by 262
Self-citationToura, I., Kawano, T., Akutsu, Y., et al. (1999) · PubMed · Cited by 260
Toura, I., Kawano, T., Akutsu, Y., Nakayama, T., Ochiai, T., & Taniguchi, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2387 · Cited by 235
Cytotoxic NK1.1 Ag+ alpha beta T cells with intermediate TCR induced in the liver of mice by IL-12.
Hashimoto, W., Takeda, K., Anzai, R., Ogasawara, K., Sakihara, H., Sugiura, K., Seki, S., & Kumagai, K. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.9.4333 · Cited by 219
Nakagawa, R., Nagafune, I., Tazunoki, Y., Ehara, H., Tomura, H., Iijima, R., Motoki, K., Kamishohara, M., & Seki, S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6578 · Cited by 216
NKT cells and tumor immunity—a double-edged sword
Smyth, M. J., & Godfrey, D. I. (2000) · Nature Immunology · doi:10.1038/82698 · Cited by 209
Self-citationContribution of Natural Killer Cells to Inhibition of Angiogenesis by Interleukin-12
Yao, L., Sgadari, C., Furuke, K., Bloom, E. T., Teruya-Feldstein, J., & Tosato, G. (1999) · Blood · doi:10.1182/blood.v93.5.1612 · Cited by 201
Nakagawa, R., Motoki, K., Ueno, H., Iijima, R., Nakamura, H. K., Kobayashi, E., Shimosaka, A., & Koezuka, Y. (1998) · PubMed · Cited by 194
Hayakawa, Y., Takeda, K., Yagita∥, H., Kakuta, S., Iwakura, Y., Kaer, L. V., Saiki, I., & Okumura, K. (2001) · PubMed · Cited by 184
The CD1 family of lipid antigen-presenting molecules
Porcelli, S. A., Segelke, B. W., Sugita, M., Wilson, I. A., & Brenner, M. B. (1998) · Immunology Today · doi:10.1016/s0167-5699(98)01289-4 · Cited by 166
Hayakawa, Y., Takeda, K., Yagita, H., Kakuta, S., Iwakura, Y., Van Kaer, L., Saiki, I., & Okumura, K. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200106)31:6<1720::aid-immu1720>3.0.co;2-u · Cited by 161
Selective Bystander Proliferation of Memory CD4+ and CD8+ T Cells Upon NK T or T Cell Activation
Eberl, G., Brawand, P., & MacDonald, H. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.8.4305 · Cited by 158
Fas/Fas Ligand Interactions Promote Activation-Induced Cell Death of NK T Lymphocytes
Leite‐de‐Moraes, M., Herbelin, A., Gouarin, C., Koezuka, Y., Schneider, E., & Dy, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.8.4367 · Cited by 109
Leite‐de‐Moraes, M., Moreau, G., Arnould, A., Machavoine, F., Cordier, C., Papiernik, M., & Dy, M. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199805)28:05<1507::aid-immu1507>3.0.co;2-f · Cited by 102
Gee, M. S., Koch, C. J., Evans, S. M., Jenkins, W. T., Pletcher, C. H., Moore, J. S., Koblish, H. K., Lee, J. J., Lord, E. M., Trinchieri, G., et al. (1999) · PubMed · Cited by 75
IL-7 reverses NK1+ Tcell-defective IL-4 production in the non-obese diabetic mouse
Gombert, J., Tancrède‐Bohin, E., Hameg, A., Leite‐de‐Moraes, M., Vicari, A. P., Bach, J., & Herbelin, A. (1996) · International Immunology · doi:10.1093/intimm/8.11.1751 · Cited by 68
Hameg, A., Gouarin, C., Gombert, J., Hong, S., Kaer, L. V., Bach, J., & Herbelin, A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.12.7067 · Cited by 54
Vicari, A. P., Herbelin, A., Leite‐de‐Moraes, M., von Freeden-Jeffry, U., Murray, R., & Zlotnik, A. (1996) · International Immunology · doi:10.1093/intimm/8.11.1759 · Cited by 43
Boesen, M., Svane, I. M., ENGEL, A. ‐., Rygaard, J., Thomsen, A. R., & Werdelin, O. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01292.x · Cited by 24
Epstein-Barr virus-dependent lymphoproliferative disease: critical role of IL-6
(2000) · Pure Amsterdam UMC · doi:10.1002/1521-4141(200007)30:7 · Cited by 1
Cited by
Bendelac, A., Savage, P. B., & Teyton, L. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141711 · Cited by 2,155
Natural Innate and Adaptive Immunity to Cancer
Vesely, M. D., Kershaw, M. H., Schreiber, R. D., & Smyth, M. J. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101324 · Cited by 2,101
Self-citationInterferons, immunity and cancer immunoediting
Dunn, G. P., Koebel, C. M., & Schreiber, R. D. (2006) · Nature Reviews Immunology · doi:10.1038/nri1961 · Cited by 1,617
Swann, J. B., & Smyth, M. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31405 · Cited by 1,447
Self-citationCD1: Antigen Presentation and T Cell Function
Brigl, M., & Brenner, M. B. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104608 · Cited by 1,035
Metadata
- Authors
- Crowe, N. Y., Smyth, M. J., & Godfrey, D. I.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2002-07-01
- Volume
- 196
- Issue
- 1
- Pages
- 119-127
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2107750829
- Cited by
- 352
- References
- 44
- FWCI
- 6.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.